Gliclazide MR in the structure of antihyperglycemic therapy according to the data of Moscow region diabetes register

Author:

Misnikova I. V.1ORCID,Kovaleva Yu. A.1ORCID,Gubkina V. A.1ORCID,Dreval A. V.1ORCID

Affiliation:

1. Moscow Regional Research and Clinical Institute

Publisher

Endocrinology Research Centre

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. Montvida O, Shaw J, Atherton JJ, et al. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes. Diabetes Care. 2018;41(1):69-78. doi: https://doi.org/10.2337/dc17-1414

2. Buse JB, Wexler DJ, Tsapas A, et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63(2):221-228. doi: https://doi.org/10.1007/s00125-019-05039-w

3. International Diabetes Federation (IDF) (2020). IDF Clinical practice recommendations for managing type 2 diabetes in primary care. 2017. Available from: https://www.idf.org/our-activities/care-prevention/type-2-diabetes.html. Accessed 21 Jan 2020.

4. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. 2015. Available from: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-pdf-1837338615493. Accessed 21 Jan 2020.

5. World Health Organization. Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose in non-pregnant adults with diabetes mellitus. Geneva: World Health Organization; 2018.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. SAFETY OF HYPOGLYCEMIC THERAPY IN CASES OF PATIENTS WITH POLYMORBID PATHOLOGIES;Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ);2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3